Cargando…
Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea
The purpose of this study was to evaluate the pharmacokinetics of intravenous (IV) ondansetron in a population of hospitalized dogs exhibiting clinical signs of nausea. The causes of nausea included pancreatitis, gastroenteritis, endocarditis, chemotherapy‐induced nausea, diabetes mellitus and ketoa...
Autores principales: | Sotelo, Cindy K., Shropshire, Sarah B., Quimby, Jessica, Simpson, Sydney, Gustafson, Daniel L., Zersen, Kristin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796123/ https://www.ncbi.nlm.nih.gov/pubmed/35899472 http://dx.doi.org/10.1111/jvp.13087 |
Ejemplares similares
-
The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome
por: Foth, S., et al.
Publicado: (2021) -
Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study
por: Kenward, Hannah, et al.
Publicado: (2017) -
Comparing the effect of intravenous dexamethasone, intravenous ondansetron, and their combination on nausea and vomiting in cesarean section with spinal anesthesia
por: Sane, Shahryar, et al.
Publicado: (2015) -
Ondansetron: Lack of efficacy in nausea and vomiting: case report
Publicado: (2021) -
Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting
por: Matsota, Paraskevi, et al.
Publicado: (2015)